- Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
-
Marcuzzi A, Zanin V, Vuch J, Pontillo A, Crovella S
- KMID: 1785977
- J Korean Med Sci.
- 2011 Jun;26(6):848-849.
- doi: 10.3346/jkms.2011.26.6.848
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
-
Lim MJ, Kwon SR, Park SG, Park W
- KMID: 1785905
- J Korean Med Sci.
- 2010 Sep;25(9):1277-1283.
- doi: 10.3346/jkms.2010.25.9.1277
We investigated acute effects of intermittent large dose bisphophonate therapy in osteoporotic patients. Peripheral blood mononuclear cells were incubated with alendronate (100 micrometer) for 18 hr, in vitro and cytokine... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
-
Lee YH, Song GG
- KMID: 1022174
- Korean J Intern Med.
- 2011 Sep;26(3):340-347.
- doi: 10.3904/kjim.2011.26.3.340
BACKGROUND/AIMS: The aim of this study was to assess the efficacy and safety of monthly oral 150 mg ibandronate in women with postmenopausal osteoporosis (PMO). METHODS: A systematic review and meta-analysis... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term Efficacy of Monthly Pamidronate Infusion in Patients with Osteogenesis Imperfecta
-
Choi JH, Shin YL, Yoo HW
- KMID: 1713163
- J Korean Med Sci.
- 2007 Apr;22(2):209-212.
- doi: 10.3346/jkms.2007.22.2.209
We evaluated the efficacy of a monthly infusion of pamidronate on the frequency of fractures, biochemical effects, and bone mineral density in children with osteogenesis imperfecta. Eleven patients from 0.9... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Treatment with Vitamin K2 and Bisphosphonate in Postmenopausal Women with Osteoporosis
-
Iwamoto J, Takeda T, Ichimura S
- KMID: 2428340
- Yonsei Med J.
- 2003 Oct;44(5):751-756.
Vitamin K2, as well as bisphosphonates, such as etidronate, alendronate, and risedronate, is widely used in the treatment with osteoporosis in Japan. Etidronate increases the lumbar bone mineral density (BMD),... -
- CITED
-
- Close
- SHARE
-
- Close
